Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.840
+0.010 (1.19%)
Oct 24, 2024, 3:59 PM EDT - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $7.82 million as of October 24, 2024. Its market cap has decreased by -92.66% in one year.
Market Cap
7.82M
Enterprise Value
15.63M
1-Year Change
-92.66%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since September 10, 2021, Calidi Biotherapeutics's market cap has decreased from $248.50M to $7.82M, a decrease of -96.85%. That is a compound annual growth rate of -66.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 6.70M | -87.48% |
| Dec 29, 2023 | 53.50M | -46.77% |
| Dec 30, 2022 | 100.50M | -64.36% |
| Dec 31, 2021 | 282.00M | 13.48% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jaguar Health | 10.81M |
| RedHill Biopharma | 10.68M |
| Alterity Therapeutics | 10.67M |
| GlycoMimetics | 10.64M |
| TransCode Therapeutics | 10.53M |
| Mustang Bio | 10.49M |
| Senti Biosciences | 10.44M |
| Kiora Pharmaceuticals | 10.37M |